USP6 and CDH11 Oncogenes Identify the Neoplastic Cell in Primary Aneurysmal Bone Cysts and Are Absent in So-Called Secondary Aneurysmal Bone Cysts

2004/11/01 by Andre M. Oliveira, André M. Oliveira, Antonio R. Pérez‐Atayde +10 · 29 citations
Medicine · Dentistry · #Bone Tumor Diagnosis and Treatments #Oral and Maxillofacial Pathology #Sarcoma Diagnosis and Treatment

paper · doi:10.1016/s0002-9440(10)63432-3

Cited by

• USP6 gene rearrangements occur preferentially in giant cell reparative granulomas of the hands and feet but not in gnathic location
• Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and Maxillofacial Bone Tumours
• Minimally Invasive Treatment of Aneurysmal Bone Cysts with Gelified Ethanol (DiscoGel®): Evaluation of Feasibility, Safety, and Efficacy
• The 2020 WHO Classification of Tumors of Bone: An Updated Review
• Giant cell tumor of bone: a neoplasm or a reactive condition? [europepmc]
• Is sclerotherapy better than intralesional excision for treating aneurysmal bone cysts? [europepmc]
• TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB. [europepmc]
• The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling. [europepmc]
• Atypical mechanism of NF-κB activation by TRE17/ubiquitin-specific protease 6 (USP6) oncogene and its requirement in tumorigenesis. [europepmc]
• Percutaneous doxycycline treatment of aneurysmal bone cysts with low recurrence rate: a preliminary report. [europepmc]
• A comparison of cyst wall curettage and en bloc excision in the treatment of aneurysmal bone cysts. [europepmc]
• Response of an aggressive periosteal aneurysmal bone cyst (ABC) of the radius to denosumab therapy. [europepmc]
• Aneurysmal bone cysts: do simple treatments work? [europepmc]
• USP6 gene rearrangements occur preferentially in giant cell reparative granulomas of the hands and feet but not in gnathic location. [europepmc]
• Giant cell lesions of the craniofacial bones. [europepmc]
• Jak1-STAT3 Signals Are Essential Effectors of the USP6/TRE17 Oncogene in Tumorigenesis. [europepmc]
• The emerging role of deubiquitinating enzymes in genomic integrity, diseases, and therapeutics. [europepmc]
• Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Odontogenic and Maxillofacial Bone Tumors. [europepmc]
• Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication. [europepmc]
• Diagnosing and discriminating between primary and secondary aneurysmal bone cysts. [europepmc]
• Targeting deubiquitinase USP28 for cancer therapy. [europepmc]
• Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results. [europepmc]
• Challenges in the Diagnosis and Treatment of Aneurysmal Bone Cyst in Patients with Unusual Features. [europepmc]
• Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases. [europepmc]
• The role of deubiquitinating enzymes in gastric cancer. [europepmc]
• Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics. [europepmc]
• Primary Aneurysmal Bone Cyst and Its Recent Treatment Options: A Comparative Review of 74 Cases. [europepmc]
• Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 ( HMGA2 ) and Nuclear Receptor Co-repressor 2 ( NCOR2 ) in Osteoclastic Giant Cell-rich Tumors of Bone. [europepmc]
• Update on aneurysmal bone cyst: pathophysiology, histology, imaging and treatment. [europepmc]